PRECIPIO, INC. Accounts Receivable, Allowance for Credit Loss, Current
PRECIPIO, INC. (PRPO) had Accounts Receivable, Allowance for Credit Loss, Current of $1.29 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss, Current $1.29M.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss, Current $1.29M.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss, Current $1.04M.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss, Current $1.05M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current |
|---|---|
| 2026-06-30 | $1.29M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.29M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.04M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $1.05M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $932.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $957.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $995.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $2.75M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $2.68M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $2.65M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $2.57M 10-K · filed 2025-03-27 |
| 2022-12-31 | $2.35M 10-K · filed 2024-03-29 |
| 2014-12-31 | $7.95M 10-K · filed 2015-04-15 |
| 2013-12-31 | $3.84M 10-K · filed 2015-04-15 |
| 2012-12-31 | $2.17M 10-K · filed 2014-03-27 |
| 2011-12-31 | $1.09M 10-K · filed 2013-03-14 |
| 2011-06-30 | $1.39M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $334.00K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |